Diagnostics News and Research

RSS
'Synthetic lethality' could be exploited for cancer therapy

'Synthetic lethality' could be exploited for cancer therapy

28 Jul 2020
A new cell-based gene therapy approach to better treat patients with hemophilia A

A new cell-based gene therapy approach to better treat patients with hemophilia A

28 Jul 2020
UArizona aims to develop a device for quick and accurate detection of pathogens, biological threats

UArizona aims to develop a device for quick and accurate detection of pathogens, biological threats

28 Jul 2020
Simultaneous mutation of two nonessential genes can cause cancer cell death

Simultaneous mutation of two nonessential genes can cause cancer cell death

28 Jul 2020
Brigham to play two key roles in phase 3 trial of COVID-19 vaccine candidate

Brigham to play two key roles in phase 3 trial of COVID-19 vaccine candidate

27 Jul 2020
New approach could enable wider adoption of COVID-19 testing for diagnosis in research laboratories

New approach could enable wider adoption of COVID-19 testing for diagnosis in research laboratories

27 Jul 2020
Scientists develop COVID-19 test to detect neutralizing antibodies with high sensitivity, specificity

Scientists develop COVID-19 test to detect neutralizing antibodies with high sensitivity, specificity

25 Jul 2020
Study identifies mechanisms that underlie olfactory symptoms of COVID-19

Study identifies mechanisms that underlie olfactory symptoms of COVID-19

25 Jul 2020
Olfactory cell types are most vulnerable to COVID-19 infection, shows study

Olfactory cell types are most vulnerable to COVID-19 infection, shows study

25 Jul 2020
Researcher receives Outstanding Investigator Award for groundbreaking microvascular and circulation research

Researcher receives Outstanding Investigator Award for groundbreaking microvascular and circulation research

25 Jul 2020
MP Biomedicals and A*STAR jointly develop rapid antibody test kit for COVID-19

MP Biomedicals and A*STAR jointly develop rapid antibody test kit for COVID-19

From MP Biomedicals, LLC 25 Jul 2020
Non-invasive urine test being offered free to the NHS to help clear bladder cancer diagnoses backlog

Non-invasive urine test being offered free to the NHS to help clear bladder cancer diagnoses backlog

25 Jul 2020
Pandemic to accelerate the adoption of technology-enabled care for epilepsy

Pandemic to accelerate the adoption of technology-enabled care for epilepsy

24 Jul 2020
SphingoTec launches point-of-care test for bio-ADM, a biomarker for life threatening endothelial dysfunction

SphingoTec launches point-of-care test for bio-ADM, a biomarker for life threatening endothelial dysfunction

24 Jul 2020
Life science diagnostic start up is seeing growing interest and support for disease detection tests

Life science diagnostic start up is seeing growing interest and support for disease detection tests

24 Jul 2020
Engineered SARS-CoV-2 spike protein is more stable and can generate larger yields in the lab

Engineered SARS-CoV-2 spike protein is more stable and can generate larger yields in the lab

23 Jul 2020
States search for ways to deal with COVID-19 testing backlogs

States search for ways to deal with COVID-19 testing backlogs

23 Jul 2020
siRNA-based treatment can reduce psoriasis symptoms

siRNA-based treatment can reduce psoriasis symptoms

23 Jul 2020
NIH leaders create a framework to scale up testing technologies for COVID-19

NIH leaders create a framework to scale up testing technologies for COVID-19

23 Jul 2020
SphingoTec introduces a CE-IVD-marked point-of-care test to determine blood levels of bio-ADM

SphingoTec introduces a CE-IVD-marked point-of-care test to determine blood levels of bio-ADM

22 Jul 2020

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback